Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.88
0.093.23%
At close: Jan 21, 4:00 PM EST
$2.81
-0.07-2.43%
After Hours: 6:02 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Annovis Bio (ANVS) stock?
You can purchase shares of Annovis Bio (NYSE:ANVS) through any online brokerage.
Who are Annovis Bio (ANVS) competitors?
Other companies in Annovis Bio’s space includes: InflaRx NV (NASDAQ:IFRX), Gain Therapeutics Inc (NASDAQ:GANX), Korro Bio Inc (NASDAQ:KRRO), Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) and Atossa Therapeutics Inc (NASDAQ:ATOS).
What is the forecast, or price target, for Annovis Bio (ANVS) stock?
Annovis Bio has a consensus price target of $30.86.
What is the current price for Annovis Bio (ANVS)?
The stock price for Annovis Bio (NYSE: ANVS) is $2.88 last updated January 21, 2026 at 7:00 PM EST.
Does Annovis Bio (ANVS) pay a dividend?
There are no upcoming dividends for Annovis Bio.
When is Annovis Bio (NYSE:ANVS) reporting earnings?
Annovis Bio does not have any upcoming earnings scheduled.
Is Annovis Bio (ANVS) going to split?
There is no upcoming split for Annovis Bio.
What sector and industry does Annovis Bio (ANVS) operate in?
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
